Your session is about to expire
← Back to Search
Coronally positioned tunnel with AlloDerm RTM and Enamel Matrix Derivative for Gingival Recession
Study Summary
This trial will compare treatments to improve gum recession in 24 patients, measuring improvements in 6 months.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of alcohol abuse.Your cemento-enamel junction cannot be clearly identified.You have had dental restorations done on the root surface where the gum has receded.You are not allowed to use any form of tobacco, including smoking, chewing tobacco, or using e-cigarettes.You have severe conditions that affect your entire body, oral health, or mental well-being, which could make it difficult for you to participate in the study.You have had a previous surgery or treatment to address gum recession at the same area.
- Group 1: Coronally positioned tunnel with AlloDerm RTM and Enamel Matrix Derivative
- Group 2: Coronally positioned tunnel with AlloDerm RTM
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How perilous is the combination of Coronally positioned tunnel with AlloDerm RTM and Enamel Matrix Derivative for individuals?
"Due to the fact this is a Phase 4 trial, meaning it has been approved by regulatory bodies, our analysts at Power assign Coronally positioned tunnel with AlloDerm RTM and Enamel Matrix Derivative a safety rating of 3."
Are there presently opportunities to join this research trial?
"Affirmative, the facts on clinicaltrials.gov reveal that this investigation is actively recruiting participants. It was first posted in October 6th 2022 and most recently updated on November 8th 2022 to include a search for 24 individuals at one location."
What is the threshold of enrolment for this trial?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial is still accepting participants and was first published on October 6th 2022. The most recent update occurred on November 8th 2021 and 24 patients need to be enrolled at one site."
Share this study with friends
Copy Link
Messenger